Skip Navigation

Lifequest's Subsidiary Biopipe Commissions First Plant in California and Receives Second Order for Its Sludge Free Sewage Treatment Plant

RIDGEFIELD PARK, NJ - (NewMediaWire) - November 10, 2020 - LIFEQUEST WORLD CORP (LQWC) subsidiary,Biopipe Global Corp., which developed the world’s only highly scalable onsite sludge, odor and chemical free sewage wastewater treatment technology, has successfully commissioned its first plant in southern California and received another order for a 10m3/day (3,000GPD), which will be installed at a winery in Napa Valley, CA.   


Max Khan, President & CEO of Lifequest,said, “We successfullycompleted the start-up of our first plant in California. This is a major milestone for the introduction of Biopipe system in North America. Almost every potential customer asks if we have a plant here in the United States. The second order is significant because it will be in a Napa Valley winery, where a competitor’s system has failed to meet the discharge standards. North America hasa large addressable market and we can sell our system at very attractive margins. We have received several inquiries in the past few weeks and we are working to convert them into sales in the near future.During the quarter, we have also made strongprogressin our key markets.We successfully commissioned the first plant in South Africa( We expect to firm up additional orders in Bangladesh, Ethiopia and India. We are also making headway with our Abrimix industrial wastewater treatment solution as well.”

Pieter Jansen, President, Biopipe Africa, said, “We are delighted to have the reference plant now in South Africa and St. Andrews College is quite impressed by the Biopipe system. This installation is expected toaccelerate our sales and marketing and we are already working on several opportunitiesin South Africa and Mozambique.We have also entered into a channel partnership with an engineering advisory firm to expand into western Africa. We are excited about Biopipe and all the emerging opportunities.”

About Lifequest & Biopipe

Lifequest offers both effluent treatment (ETP) and sewage treatment (STP) solutions. Biopipe, a wholly owned subsidiary, has developed a patented 100% sludge-free, chemical-free, odor-free, silent, easy to assemble and install, scalable, low cost, ecological and virtually maintenance-free onsite sewage wastewater treatment system. It treats both grey and black water.  The treated water exceeds EU and all local standards for discharge and can be reused for irrigation, flushing and cleaning.  Our Abrimix ETP solution is a highly efficient and cost-effective industrial wastewater treatment system that is vastly superior to Dissolved Air Floatation (DAF) systems.


Biopipe Africa

Name: Jeroen Rietveld



Investor Relations

TraDigital Marketing Group, Inc.

Kevin McGrath



This press release contains forward-looking statements that reflect the Company's current beliefs, expectations or intentions regarding future events.  Any statements contained in this press release that are not statements of historical fact may be deemed forward-looking statements.  Words such as "will," "will be," "anticipate," "predict," “expect” "continue," "future," and similar expressions are intended to identify such forward-looking statements. All forward-looking statements involve significant risks and uncertainties that could cause actual results to differ materially from those expressed or implied in the forward-looking statements, many of which are generally outside the control of the Company and are difficult to predict.  Examples of such risks and uncertainties include, but are not limited to: future revenues, expenditures, capital, the adequacy of the Company's current cash and working capital to fund present and planned operations, and the growth through joint ventures. Additional factors that could cause actual results to differ materially from those expressed or implied in the forward-looking statements, can be found in our current Disclosure Statements at The Company anticipates that subsequent events and developments may cause views and expectations to change. The Company assumes no obligation, and specifically disclaims any intention or obligation, to update any forward-looking statements, whether as a result of new information, future events or otherwise.